Delivery Order SPE2DB24D2100-SPE2DB25FBDSH
Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,251.07 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed-price delivery order represents a pediatric pharmaceutical supply under a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $1,581.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on November 4, 2025, with completion required by November 5, 2025. This non-set-aside contract represents a standard pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military...
- The Defense Logistics Agency awarded a $4,620.72 delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a small-value transaction within AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $1,131.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on August 19, 2025, with completion scheduled for August 20, 2025. This non-set-aside contract represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,186.01 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on October 23, 2025, with completion scheduled for October 24, 2025. The award employs firm fixed price pricing and carries no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,993.88 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,282.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,253.16 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 198 mg, a testosterone replacement therapy medication. The contract was competitively awarded without set-aside designation on July 21, 2025, with an ultimate completion date of July 22, 2025. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under firm fixed-price terms and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jatenzo 237 mg capsules (120-count units) with a ceiling value of $1,226.39. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. No set-aside designation was used in this competitive award. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 120 count bottles of Jatenzo 198 mg capsules, with a ceiling value of $1,716.84 and a firm fixed price structure. The award, issued on October 30, 2025, is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor will...